Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma

European Urology
Eero KaasinenFinnBladder Group

Abstract

To study the factors determining new recurrences in patients with frequently recurring superficial bladder tumors. Of all 205 eligible patients, each received 5 weekly intravesical instillations of mitomycin C (MMC), with the first instillation given perioperatively. This was followed, according to randomization, by BCG instillations alone or by alternating instillations of interferon-alpha and BCG monthly for up to 1 year. Impact of 12 variables on time to first recurrence was retrospectively studied with the Cox multiple hazards regression and Kaplan-Meier analysis. Type of regimen was the most significant factor determining new recurrences, with preceding recurrence rate being the most important prognostic factor. Timing of the first MMC was the third significant predictor in the main multivariate analysis, with more than a two-fold relative risk for a new recurrence if the first MMC instillation was given later than on day 0. Preceding recurrence rate, most accurately reflects, in patients with frequently recurring tumors, the inherent risk for new recurrences. This risk can be considerably reduced by use of an effective chemoimmunotherapy regimen, and in addition, by inclusion of an early perioperative chemotherapy instill...Continue Reading

References

Dec 1, 1981·British Journal of Urology·P H AbramsN A Green
Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Karl Heinz KurthWillem Oosterlinck
Jun 21, 2002·European Urology·Willem OosterlinckEuropean Association of Urology (EAU) Working Group on Oncological Urology

Citations

Dec 14, 2004·Der Urologe. Ausg. A·S LangbeinPeter Alken
Mar 10, 2009·World Journal of Urology·K D SievertA Stenzl
Nov 30, 2010·World Journal of Urology·Alon Z WeizerJeffrey S Montgomery
Aug 5, 2011·Indian Journal of Urology : IJU : Journal of the Urological Society of India·M Manoharan
May 13, 2008·European Urology·Marko BabjukEuropean Association of Urology (EAU)
Jul 5, 2016·Bladder Cancer·Nicholas E Power, Jonathan Izawa
Apr 2, 2013·The Urologic Clinics of North America·David C JohnsonMichael E Woods
Apr 5, 2011·European Urology·Marko BabjukEuropean Association of Urology (EAU)
Mar 27, 2007·Seminars in Oncology·Michael A O'Donnell
Nov 10, 2012·International Journal of Clinical Practice·T R L Griffiths, Action on Bladder Cancer
Dec 5, 2012·BJU International·Callum LoganDickon Hayne
Jun 14, 2008·Expert Opinion on Investigational Drugs·J Alfred Witjes, Prasad S Kolli
Dec 21, 2010·European Urology·Willem OosterlinckEuropean Association of Urology Guidelines Committee on Non-Muscle-Invasive Bladder Tumors
Jun 28, 2016·Lancet·Ashish M KamatWassim Kassouf
Apr 9, 2005·Surgical Oncology Clinics of North America·Federico A Corica, Thomas E Keane
Oct 4, 2012·Expert Review of Anticancer Therapy·Willem Oosterlinck, Karel Decaestecker
Aug 24, 2006·Expert Review of Anticancer Therapy·Christian BolenzMaurice Stephan Michel
Nov 30, 2010·Expert Review of Anticancer Therapy·Rianne J M Lammers, J Alfred Witjes
Jan 10, 2006·Urology·Willem OosterlinckPaul Sved
Nov 7, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Iori SakaiMasato Fujisawa
Mar 13, 2018·Expert Review of Anticancer Therapy·Willem Oosterlinck, Karel Decaestecker
Jan 31, 2018·Frontiers in Pharmacology·Julieti Huch BussFabiana Kömmling Seixas
Jan 14, 2011·Nature Reviews. Urology·Johannes Falke, J Alfred Witjes
Oct 8, 2016·Urologia·Vincenzo SerrettaGiovanni Caruana
Aug 2, 2008·Current Opinion in Urology·Joerg Schmidbauer, Gabriele Lindenau
Feb 3, 2010·BJU International·Benjamin E AyresAction for Bladder Cancer
Jun 28, 2008·Journal of Korean Medical Science·Sung Joon HongKorean Urological Oncology Society
Jan 9, 2020·The Cochrane Database of Systematic Reviews·Stefanie SchmidtJoerg J Meerpohl
Aug 15, 2003·Current Opinion in Urology·Jean-Jacques PatardBernard Lobel
May 12, 2011·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Anna M LeliveldIgle J de Jong
Aug 1, 2013·British Journal of Nursing : BJN·Beverley Anderson
Aug 16, 2018·F1000Research·Justin T Matulay, Ashish M Kamat

Related Concepts

Immunologic Adjuvants
Antibiotics, Cytotoxic
BCG Vaccine
Malignant Neoplasm of Urinary Bladder
Drug Administration Schedule
Neoplasm Recurrence, Local
Cox Proportional Hazards Models
Mutamycin

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.